Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1CNS 1

Conditions

Neuroblastoma 44Medulloblastoma 9Lymphoma 9Sarcoma 8Brain Neoplasms 8Neuroectodermal Tumors, Primitive, Peripheral 7Central Nervous System Neoplasms 7Rhabdomyosarcoma 6Precursor Cell Lymphoblastic Leukemia-Lymphoma 6Wilms Tumor 5Sarcoma, Ewing 5Leukemia 5Ganglioneuroblastoma 5Burkitt Lymphoma 5Astrocytoma 5Rhabdoid Tumor 4Lymphoma, Non-Hodgkin 4Lymphoma, Mantle-Cell 4Lymphoma, Large-Cell, Immunoblastic 4Lymphoma, Large B-Cell, Diffuse 4Lymphoma, Follicular 4Lymphoma, B-Cell, Marginal Zone 4Leukemia, Myeloid, Acute 4Leukemia, Lymphocytic, Chronic, B-Cell 4Hepatoblastoma 4Glioma 4Dendritic Cell Sarcoma, Interdigitating 4Testicular Neoplasms 3Retinoblastoma 3Recurrence 3

Interventions

Temozolomide 6Cyclophosphamide 5Magnetic Resonance Spectroscopy 4Carboplatin 4etoposide phosphate 3Thiotepa 3Surgical Procedures, Operative 3Irinotecan 3Filgrastim 3Automobiles 3temsirolimus 2fludarabine 2entinostat 2Vincristine 2Radiotherapy, Conformal 2Proton Therapy 2Peripheral Blood Stem Cell Transplantation 2Nivolumab 2Isotretinoin 2Granulocyte Colony-Stimulating Factor 2Gadolinium DTPA 2Etoposide 2Donepezil 2Cisplatin 2Celecoxib 2Bevacizumab 2Amplified Fragment Length Polymorphism Analysis 22-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole 2trametinib 1tozuleristide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Pinealoma × Melphalan × CNS × Clear all
NCT00253721 2017-04-21

Melphalan With BBBD in Treating Patients With Brain Malignancies

OHSU Knight Cancer Institute

Phase 1 Terminated
21 enrolled
CNSLymphoid

Astrocytoma, Brain Neoplasms, Glioma, Lymphoma, Medulloblastoma, Neoplasm Metastasis, Oligodendroglioma, Pinealoma, Central Nervous System Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡